Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23118268 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
Conditions: Pneumococcal Disease;   Haemophilus Infection
Interventions: Biological: GSK Biologicals´ Pneumococcal Conjugate Vaccine (GSK1024850A);   Biological: Infanrix™ hexa.;   Biological: Pediacel™;   Biological: Prevenar™

Indicates status has not been verified in more than two years